136 results on '"Roti, G"'
Search Results
2. 1061P Static and dynamic tracking of radiomic and immunophenotypic features predicts the benefit of immune checkpoint inhibitors in advanced NSCLC
3. P1.15-04 Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer
4. 1328P Dynamic blood immune-inflammatory and radiomic profiling to decode distinct patterns of acquired resistance to immunotherapy in NSCLC patients
5. 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia
6. P336: A CHEMOTRANSCRIPTOMIC SCREENING IDENTIFIES THE REVERSAL OF GLUCOCORTICOID RESISTANCE IN NOTCH1 MUTATED T-ALL
7. Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia
8. 17P Dynamic changes of CT-radiomic and systemic immune-inflammatory features predict the response to immune checkpoint inhibitors in advanced NSCLC patients
9. A distinct epigenetic program underlies the 1;7 translocation in myelodysplastic syndromes
10. 2315P Clinical and blood immune-inflammatory profiling to decode different patterns of acquired resistance in immunotherapy treated NSCLC patients
11. Different genomic imbalances in low- and high-grade HCV-related lymphomas
12. A new NDE1/PDGFRB fusion transcript underlying chronic myelomonocytic leukaemia in Noonan Syndrome
13. Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations
14. 189P The parallel interrogation of tissue and peripheral blood immune features unveils a bidirectional crosstalk with clinical impact on resected NSCLC
15. Structure of the (SR) Ca2+-ATPase bound to the inhibitor compound CAD204520 and TNP-ATP
16. Identification of a radio-immune signature with high prognostic value in surgically resected NSCLC
17. PF158 TARGETING ONCOGENIC NOTCH1 IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITH A NEW SELECTIVE SERCA INHIBITOR CAD204520
18. Differentially regulated high-throughput CT imaging features correlate to distinct tumor immune contextures portraying a radiomic signature with prognostic impact on surgically resected NSCLC
19. Advanced CT imaging features reflect distinct tissue immune profiles and exhibit high prognostic impact on NSCLC
20. BEPRIDIL IS A POTENT NOTCH1 INHIBITOR AND EFFICIENTLY INDUCES APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) CELLS in vitro AND in vivo
21. 1982PD - Identification of a radio-immune signature with high prognostic value in surgically resected NSCLC
22. 1O - Advanced CT imaging features reflect distinct tissue immune profiles and exhibit high prognostic impact on NSCLC
23. Genetic pathways in low-and high-grade HCV-related lymphomas are different
24. Immunohistochemistry predicts nucleophosmin (NPM) mutations in acutemyeloid leukemia
25. Quantitative assessment of minimal residual disease in acute myeloidleukemia carrying nucleophosmin (NPM1) gene mutations
26. Angiopoietins expression by human myeloma cells
27. Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML
28. Genetic and proteomic approaches to identify cancer drug targets
29. Different genomic imbalances in low- and high-grade HCV-related lymphomas
30. C022 NPM1 monoallelic deletion in a subgroup of MDS/AML with del (5q) or monosomy 5 and complex karyotype
31. Cryptic chromosome 9q34 deletion generates TAF-I /CAN and TAF-I /CAN fusion transcripts in acute myeloid leukemia
32. Genetic and proteomic approaches to identify cancer drug targets.
33. PREVALENCE AND PROGNOSTIC ROLE OF IDH MUTATIONS IN ACUTE MYELOID LEUKEMIA: FIRST RESULTS OF THE AML1516 GIMEMA PROTOCOL
34. 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia
35. The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia.
36. A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes
37. Cytoplasmic nucleophosmin in myeloid sarcoma occurring 20 years after diagnosis of acute myeloid leukaemia.
38. 2O Differentially regulated high-throughput CT imaging features correlate to distinct tumor immune contextures portraying a radiomic signature with prognostic impact on surgically resected NSCLC.
39. Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML
40. Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations
41. Long-term survival can be achieved in a significant fraction of older patients with core binding factor acute myeloid leukemia treated with intensive chemotherapy.
42. Discovery of a new 1-(phenylsulfonyl)-1H-indole derivative targeting the EphA2 receptor with antiproliferative activity on U251 glioblastoma cell line.
43. CD26 Is Differentially Expressed throughout the Life Cycle of Infantile Hemangiomas and Characterizes the Proliferative Phase.
44. End of induction [ 18 F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial.
45. Longitudinal Changes of CT-radiomic and Systemic Inflammatory Features Predict Survival in Advanced Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors.
46. Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study.
47. Acute lymphoblastic leukaemia.
48. Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML.
49. Myb overexpression synergizes with the loss of Pten and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemia.
50. CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.